By histopathologic examination of various organs in 3 normal strains, C3H/HeN, ICR, and DBA/1J, of mice treated intravenously once with anti-Fas antibody (Jo2), we failed to determine any target organ, except the liver, responsible for the acute lethality induced by the Fas/anti-Fas antibody interaction. However, we could show the presence of Fas-mediated apoptosis in other organs aside from the liver and normal mouse strain differences in susceptibility to anti-Fas antibody. Among these strains, C3H/HeN was the most susceptible to the antibody, followed by ICR and DBA/1J. We observed Fas-mediated apoptosis in the liver, spleen, thymus, lymph nodes, Peyer's patch, intestine, skin, coagulation glands, ovary, uterus, and vagina in all 3 strains and additionally in the epididymides and seminal vesicles in the DBA/1J strain. We also demonstrated that Fas-mediated apoptosis of small lymphocytes in the mantle zone of splenic lymphatic follicles preceded that of the hepatocytes or thymic cells. Since cellular damage was most severe in the liver among all the apoptotic organs in the 3 mouse strains, liver injury induced by anti-Fas antibody is speculated to play a significant role in the death.
INTRODUCTION
Apoptosis plays an important role in many biological processes, including embryogenesis, development of the immune system, elimination of virus-infected cells, and the maintenance of tissue homeostasis (2, 12, 18) . The Fas/Apo-1 (CD95) molecule is a cell-surface receptor belonging to the tumor necrosis factor receptor family that induces apoptosis when stimulated with agonistic anti-Fas antibody or Fas ligand (6, 7, 17, 19) . Fas messenger RNA is expressed in many organs, including the thymus, spleen, liver, heart, lung, and ovary of the mouse (6).
Ogasawara et al (10) reported that the intraperitoneal administration of anti-Fas agonist antibody (Jo2: IgG, 10 or 100 ~g per mouse) was lethal to Fas-sufficient mice (BALB/c or C3H/HeJ), causing fulminant apoptotic hepatic failure, but not lethal to Fas-deficient mice (MRL-Ipr/lpr or MRL-lprcg/lprcg). Thereafter, Lacronique et al (5) reported that the intravenous administration of anti-Fas antibody (Jo2, 10 [tg per mouse) also induced early massive hepatic apoptosis, leading to death in nontransgenic mice (CBA/B6D2), but caused delayed nonlethal hepatic apoptosis in pyruvate kinase-bcl-2 transgenic mice in which human bcl-2 complementary DNA was placed under the control of the regulatory sequence of the rat L-type pyruvate kinase gene, resulting in a 93% survival rate. These findings suggest that bcl-2 is able to protect against Fas-mediated hepatotoxicity. On the other hand, Rodriguez et al (14) reported that the intravenous administration of anti-Fas antibody (Jo2, 10 Rg per mouse) did not induce fulminant hepatic destruction in cxl-antitrypsin (AAT)-bcl-2 transgenic mice in which human bcl-2 complementary DNA was placed under the control of the hepatocyte-specific I-antitrypsin gene promoter, yet these animals died almost as rapidly as normal mice. These investigations suggested that acute lethality results from stimulation of Fas receptors on target organs or cells other than the liver.
The purpose of this study was to confirm the speculation of Rodriguez et al (14) regarding acute lethality resulting from stimulation of Fas receptors present on target organs aside from the liver by histopathologic examination of various organs in 3 normal mouse strains, C3H/HeN, DBA/lJ, and ICR, intravenously given anti-Fas antibody (Jo2).
MATERIALS AND METHODS
Animals. Seven-wk-old male and female C3H/HeN, DBA/1J, and ICR mice were purchased from Charles River Japan Inc. (Yokohama, Japan). The animals were individually housed in a room controlled at 23 ± 2°C and 55 ± 15% relative humidity with a 12-hour-light/12-hourdark cycle and given a solid diet (gamma-irradiated CRF-1, Oriental Yeast, Tokyo, Japan) with water ad libitum during the experimental period.
Test Substance. The hamster monoclonal antibody (Jo2: IgG) against mouse Fas antigen used was described earlier (10) . Hamster IgG (Cappel, Organon Teknika Corp., NC) served as the control IgG. The control IgG was treated with an endotoxin adsorbent (Pyrosep-C, Tanabe Seiyaku Co., Ltd., Osaka, Japan) to adjust the endotoxin concentration to that in Jo2. The endotoxin concentrations in the Jo2 and the control IgG were below 0.1 ngi~,~. The animals were injected intravenously once A-F) Apoptotic lymphocytes (arrowheads) are located in the mantle zone in all 3 strains. Areas of congestion also correspond to the mantle zone. X50 (A, C, E) and X200 (B, D, F). mus, spleen, submandibular lymph nodes, mesenteric lymph nodes, femur and bone marrow, sternum and bone marrow, urinary bladder, testes, epididymides, prostate, coagulation glands, ovary, uterus, vagina, skin, mammary glands, vastus lateralis muscles, and sciatic nerves. Except for a small portion of the spleen examined by flow cytometry, all organs were fixed in 10% phosphate-buffered formalin, routinely processed, embedded in paraffin, sectioned at 3 pLm, and stained with hematoxylin-eosin for light microscopy. Flow Cytometry. Splenic portions from each animal were minced with a surgical knife in cold PBS and filtered through a cell strainer (FALCON, Nippon Becton Dickinson, Tokyo, Japan). The cells were washed with PBS, and the density was adjusted to 1 X 107 /ml. For analysis of populations of B-and T-cells, 100 jjd of heparinized blood or the splenic cell suspension was simultaneously reacted with both fluorescein isothiocyanate (FITC)-conjugated anti-mouse CD45R/B220 antibody (Pharmingen, San Diego, CA) and phycoerythrin (PE)-conjugated anti-mouse CD3 E antibody (Pharmingen). For determination of the populations of CD8-and CD4-positive cells, both FITC-conjugated anti-mouse CD8a (Ly-2) antibody (Pharmingen) and PE-conjugated anti-mouse CD4 (L3T4) antibody (Pharmingen) were simultaneously reacted with another 100 ~,1 of the samples. After termination of these reactions, each sample was washed with PBS, hemolyzed with 0.83% ammonium chloride solution, and analyzed with a flow cytometer (EPICS ELITE, Coulter K.K., Tokyo, Japan). The numbers of lymphocytic subpopulations were calculated on the basis of the proportion of each lymphocyte type to the total number of leukocytes. The proportions of Tto B-cells (T/B ratio) and of CD4-positive to CD8-positive cells (CD4/CD8 ratio) were also calculated. Statistical Analysis. Numeric data for each group were expressed as mean ± SD (n = 3). Statistically significant differences between the hamster IgG-treated control and Jo2-treated groups were analyzed using Aspin-Welch or Student's t-test. A statistically significant difference was defined as p < 0.05.
RESULTS

General Observations
Intravenous administration of Jo2 caused moribund state immediately in C3H/HeN, within about 2 hr in ICR, and at 14 hr in DBA/1J mice, and death occurred within 1-2, 3-4, and 18-24 hr in C3H/HeN, ICR and DBA/1J mice, respectively (Fig. 1 ). The time of death between males and females did not differ in any of the strains. Moribund animals showed a decrease in locomotor activity, sopor, and bradypnea and usually assumed a lateral position.
Histopathologic Examination
Organs or cells that underwent apoptosis induced by Jo2 are summarized in Table II . The extent of apoptosis is expressed as the mean of the grading scale for each group (see legend to this table). Animals Remaining Alive 1 hr After Jo2 Administration. Characteristic apoptotic figures were seen in the midlobular hepatocytes from C3H/HeN and ICR mice ( Fig. 2A, B ); in lymphocytes in the spleen (Fig. 3 ), lymph nodes, Peyer's patch, and intestinal central lacteals from all 3 strains; and in the thymus from C3H/HeN and ICR mice. No apoptotic figures were seen in the liver and thymus from DBA/lJ mice.
The spleen of all 3 strains revealed the following noteworthy changes (Fig. 3 ): small lymphocytes in the mantle zone of lymphatic follicles underwent apoptosis and obviously decreased in number. Macrophages were remarkable on the inner border of the marginal zone, and the mantle zone was full of blood. Lymphocytes in the marginal zone showed no obvious changes. The periarterial lymphoid sheath was also apparently normal. Moreover, no abnormalities were detected in the gonadal glands or in the skin of live animals of any of the strains.
Moribund Animals. Apoptosis of midlobular hepatocytes was characteristic in all 3 strains. Sinusoids were full of blood and dilated in C3H/HeN and ICR mice, and the histologic figures of each strain at moribund state (photographs not shown) were almost the same as those of each one examined after death (Fig. 4 ).
In the spleen from moribund ICR mice, apoptotic lymphocytes were located in the mantle zone and periarterial lymphoid sheath. The number of lymphocytes was remarkably decreased in the mantle zone, and the change was associated with congestion of the area and conspicuousness of macrophages on the inner border of the marginal zone. These figures (photographs not shown) resembled those from dead C3H/HeN mice (Fig. 5A, B) .
In the spleen from moribund DBA/1J mice, the number of small lymphocytes was decreased in the white pulp. The mantle zone in the lymphatic follicles was devoid of lymphocytes (photographs not shown). These changes were similar to those seen in dead ICR mice (Fig. 5C,  D) , where the outline of the lymphatic follicle was still recognizable.
Dead Animals. Jo2-induced histopathologic changes were qualitatively similar in all strains. The degree of change and the impaired organs differed among the 3 strains, but males and females did not remarkably differ.
Apoptosis of midlobular hepatocytes was characteristic in all 3 strains. Sinusoids were full of blood and dilated in C3H/HeN and ICR mice (Fig. 4) . Changes were most remarkable in the spleen. Splenic  TABLE III. -Changes in lymphocyte count and lymphocyte subpopulations in the peripheral blood and spleen from mice treated intravenously with anti-Fas antibody. Each value is expressed as the mean -standard deviation (n = 3). * p < 0.05; ** p < 0.01. Significantly different from IgG treatment group. changes in each strain were different in degree but similar in quality. Comparing dead C3H/HeN mice with live ones at I hr after Jo2 administration, the former showed more progressively lymphocytic apoptosis in the mantle zone (Fig. 5A, B ) than the latter (Fig. 3A, B ). In this strain, lymphocytes in the marginal zone with congestion showed noticeable apoptosis and a decrease in their number. In ICR mice, lymphatic follicles were devoid of lymphocytes, and the number of lymphocytes in periarterial lymphoid sheath was decreased as in the marginal zone. f However, the outline of the white pulp was still recognizable in this strain (Fig. 5C, D) . In DBA/1J mice, few small lymphocytes were detected in the white pulp, and lymphatic follicles were no longer structurally detectable ( Fig. 5E, F) .
In other immune organs from all 3 strains, including the thymus (Fig. 6A ), the lymph nodes (Fig. 6B ), and Peyer's patches (Fig. 6C ), lymphocytes had undergone apoptosis.
In addition, epithelial cells and lymphocytes in the epithelium ( Fig. 7A ) and in the central lacteals of the intestines (Fig. 7B ), root sheath cells in the skin (Fig. 7C ), and epithelial cells of coagulation glands (Fig. 7D ) underwent apoptosis. Apoptosis of the epithelial cells in the epididymides (Fig. 7E ) and seminal vesicles (Fig. 7F) was characteristic of male DBA/1J mice. Epithelial cells and lymphocytes infiltrating into the ovary, uterus, and vagina also underwent apoptosis, but this finding was inconsistent, perhaps because of the estrous cycle.
Hematology and Flow Cytometry
One Hour After Jo2 Administration. The number of peripheral leukocytes, lymphocytes, T-cells, B-cells, CD4-positive, and CD8-positive cells was increased in all animals given Jo2 except for ICR female mice, in whom these parameters were decreased. The T/B ratio in the peripheral blood of Jo2and IgG-treated mice did not differ, but the CD4/CD8 ratio in Jo2-treated animals was decreased compared with control mice. In contrast, the splenic T/B ratio in Jo2-treated animals increased, but the CD4/CD8 ratio did not differ from that of the controls for any of the 3 strains (Table III) . (Table III) . DISCUSSION Ogasawara et al (10) initially reported that systemic administration of the anti-Fas agonist antibody, Jo2, in mice given 100 pLg per mouse induced severe apoptosis in the liver at 2 hr after the treatment but did not cause such a reaction in any other organs. Their findings were later confirmed by many investigators (5, 9, 13, 14) . Furthermore, Rodriguez et al (14) reported that phosphoglycerate kinase (PGK)-bcl-2 transgenic mice expressing antiapoptotic bcl-2 protein in their hepatocytes and other organs were resistant to the apoptotic hepatic failure induced by anti-Fas antibody, but that AAT-bcl-2 transgenic mice expressing bcl-2 protein only in their hepatocytes died almost as rapidly as normal mice treated with 10 pLg per mouse of the same antibody. These findings suggested that acute lethality results from the stimulation of Fas receptors present on target organs other than the liver. However, this concept has not yet been supported by experimental evidence, since there are few reports on systematically and time-dependently histopathologic examination of various organs or cells from mice intravenously given Jo2. Hence, using 3 normal mouse strains (C3H/HeN, ICR, and DBA/lJ), we examined whether other target organs or cells are more sensitive to anti-Fas antibody than the liver not only at the early stage after the treatment but also at moribund state and at death. Of the 3 strains, C3H/HeN mice were the most susceptible, followed by ICR and DBA/1J mice in that order. It thus became apparent that there were strain differences in sensitivity to Jo2. C3H/HeN, ICR, and DBA/1J mice died within 1-2, 3-4, and 18-24 hr, respectively, after treatment with the anti-Fas antibody. Although each strain died at a different rate, liver injury is speculated to play a significant role in the death, since we failed to find any target organs or cells other than the liver that were susceptible to the lethal effect induced by the anti-Fas antibody. Rodriguez et al (14) mentioned that the cause of death of their Jo2-treated AAT-bcl-2 transgenic mice with protected livers might have been related to stimulation of Fas receptors present on other target organs or cells. In this study, we had no histopathologic evidence showing cardiovascular or respiratory failure, but hepatic damage was more severe than that in other organs at the moribund state and at death in all strains.
Fas antigen messenger RNA is expressed in many mouse organs, including the thymus, liver, heart, lung, spleen, kidney, small intestine, lymph nodes, and ovary (15) . In the present study we also histologically identified Fas-mediated apoptosis in many organs, including the liver, spleen, thymus, lymph nodes, Peyer's patch, intestine, skin, coagulation glands, ovary, uterus, and vagina in all 3 mouse strains and in the epididymides and seminal vesicles in DBA/1J mice.
Since there is little information about the progress of histopathologic changes in immune organs and peripheral lymphocytes after the systemic administration of anti-Fas antibody, we examined them in detail over time. We demonstrated that Fas-mediated apoptosis of small lymphocytes in the mantle zone of splenic lymphatic follicles preceded that in the liver or thymus, appearing first in the mantle zone of lymphatic follicles of the spleen, and then extending to the marginal zone. The macrophages on the inner border of the mantle zone were considered to be marginal metallophilic macrophages by their arrangement (3), and these macrophages may have become conspicuous as a result of the decrease in number of lymphocytes in the mantle zone. Medium-sized lymphocytes in the marginal zone, referred to as marginal zone Blymphocytes (3) , were resistant to Fas-mediated apoptosis. Therefore, when the mantle zone became empty of lymphocytes, the marginal zone was structurally retained. Fas-mediated apoptosis of lymphocytes then proceeded in the periarterial lymphoid sheaths.
These findings suggest that small lymphocytes in the mantle zone of splenic lymphatic follicles underwent apoptosis earlier than thymic lymphocytes or lymphocytes in splenic periarterial lymphoid sheath. The histopathologic findings were supported by the results of flow cytometry of the mouse splenocytes. The T/B ratio increased at 1 hr after the treatment and decreased later. In the peripheral blood, the T/B ratio at 1 hr after the treatment did not remarkably differ from that in the corresponding control animals and tended to increase only during the moribund state. Although the number of both Tand B-cells in the peripheral blood was extensively decreased in the moribund state, the T/B ratio tended to increase. These findings suggest that changes in the peripheral blood lag behind those in the spleen.
In addition, the CD4/CD8 ratio decreased or tended to s-decrease in the peripheral blood and spleen. This finding suggests that CD4-positive cells are more susceptible to anti-Fas antibody than CD8-positive cells. This result is consistent with the findings described by Nishimura et al (9) .
Jo2-induced apoptosis in organs other than the liver was not apparent in earlier reports (5, 10, 14) , which gave the histopathologic findings only at 2 hr after Jo2 administration (10) or indicated no systemic findings (5, 14) . We investigated the mice at 1 hr after the treatment, in the moribund state, and post mortem, and thereby we demonstrated many organs that underwent apoptosis.
Moreover, we clarified mouse strain differences in susceptibility to anti-Fas antibody. The cause of the strain differences remains unknown. It is known certainly that the C3H strain has a higher incidence of hepatocellular neoplasia than the DBA strain (11) , and strain differences in susceptibility to drugs are also present (1). To clarify the mechanisms underlying the strain differences, it seems necessary to determine cross reactivities of Jo2 to the Fas receptor from each strain and expression levels of proteins (i.e., Bcl-x, Bax, Bad, Bak, and p53) also involved in resistance or sensitivity to apoptosis.
Lastly, the results of the present study indicated no Fas-mediated apoptosis in the heart, lung, kidney, and bone marrow, all of which express high levels of Fas (15) . Likewise, the testes, which express Fas and Fas ligand (15, 16) , did not undergo Fas-mediated apoptosis. Krajewska et al (4) reported that there is no relationship between apoptosis and the expression level of CPP32, a protease that induces apoptosis in various organs or cells. Considering these results, it is certain that the determination of organs or cells responsive to anti-Fas antibody in vivo is complex.
